Epidemiologic Study Evaluating Infections in Elderly Patients
October 8, 2009 updated by: Wyeth is now a wholly owned subsidiary of Pfizer
Epidemiologic Study of Infections in Elderly Patients
The purpose of this observational study is to assess the prevalence and demographic and clinical characteristics of infections in elderly people admitted to Internal Medicine wards in Spain, as well as the etiology and resistance pattern for the main causal agents, and outcome.
Study Overview
Study Type
Observational
Enrollment (Actual)
240
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Barcelona
-
Mataró, Barcelona, Spain, 08304
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
65 years and older (Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Infected elderly patients treated at Internal Medicine wards in Spanish hospitals
Description
Inclusion criteria:
- Patients > 65 years of age that are hospitalized in an Internal Medicine ward and have an active infection (skin and soft tissue, intra-abdominal, or respiratory infections) from the community that needs antibiotic treatment
- Patients must have at least one sample processed for microbiological diagnosis
Exclusion criteria:
- COPD exacerbation
- Urinary tract infections
- Hospital acquired infections
- Other infections not in inclusion criteria
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
1
Infected elderly patients
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Prevalence of each kind of infection will be measured from a descriptive point of view, using relative and absolute frequencies.
Time Frame: 5 months
|
5 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Study the etiology and resistance pattern for the main causal agents.
Time Frame: 5 months
|
5 months
|
|
Describe the demographic features, co-morbidities, concomitant treatment and outcome of patients.
Time Frame: 5 months
|
5 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2009
Primary Completion (Actual)
June 1, 2009
Study Completion (Actual)
June 1, 2009
Study Registration Dates
First Submitted
May 7, 2009
First Submitted That Met QC Criteria
May 12, 2009
First Posted (Estimate)
May 13, 2009
Study Record Updates
Last Update Posted (Estimate)
October 9, 2009
Last Update Submitted That Met QC Criteria
October 8, 2009
Last Verified
October 1, 2009
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 3074X1-4489
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.